New perspective on innate antibodies in mice
小鼠先天抗体的新视角
基本信息
- 批准号:8033790
- 负责人:
- 金额:$ 38.76万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-03-01 至 2012-02-29
- 项目状态:已结题
- 来源:
- 关键词:AccountingAnimalsAntibodiesAntibody FormationAntibody RepertoireAntigensB-Cell DevelopmentB-Lymphocyte SubsetsB-LymphocytesCell divisionCellsComplexDataDevelopmentEmployee StrikesFailureFrancisella tularensisFrequenciesGoalsGreater sac of peritoneumImmigrantImmune responseImmune systemImmunizationImmunoglobulin Class SwitchingImmunologic MemoryIn VitroIndividualInfectionInvadedKineticsLipopolysaccharidesMediatingMemoryMemory B-LymphocyteMethodsModelingMolecularMusNatural ImmunityParasitesPlasma CellsPopulationPropertySalmonella typhimuriumSerumSignal TransductionSpecificitySpleenStimulusSurfaceTLR4 geneTechnologyTimeTransgenic OrganismsWorkbasedesignin vivoin vivo Modelinsightmigrationmouse modelpathogenplasma cell differentiationpublic health relevancereceptorresponsevaccine development
项目摘要
DESCRIPTION (provided by applicant): Current concepts of innate immune responses to bacterial stimuli such as lipopolysaccharides (e.g., the LPS from S. typhimurium used here) are largely based on data from in vitro stimulation of spleen cells taken from unstimulated mice. However, our recent findings with LPS stimulation in an in vivo mouse model demonstrate that much of this in vitro data is not suitable for modeling innate responses, which occur perforce in vivo. Similarly, our findings raise questions about the how to relate data from in vivo models (B-cell transgenic, TLR- deficient, parasite infection, etc.) to LPS responses in normal (genetically intact) animals. Specifically, we find that the majority of the LPS-stimulated plasma cell response in vivo is produced by B-1a (CD5+ B-1) cells, most of which only migrate into the spleen after LPS injected. Further, we find that the immediate response to LPS in vivo is produced by the B-1a cells that are resident in the spleen and surprisingly differentiate into plasma cells within 1-2 days without undergoing cell division. This initial wave of plasma cell differentiation accounts for a relatively small proportion of the overall in vivo response, which peaks at day 3 and is largely produced by immigrant B-1a cells that divide before (or while) differentiating to plasma cells. However, the rapid response capabilities of the early responders, which can be likened to primitive immunologic memory, may be key to the ability to use the innate immune system to "fill in the gap" until the adaptive immune system can take over. Studies proposed here are designed to provide a clear view of the B cells and mechanisms that participate in innate antibody responses to invading pathogens, including but not restricted to LPS. Our findings to date demonstrate that we can work effectively with the tiny functional B cell subsets that mediate these responses (0.1-3% of spleen cells from unstimulated or LPS-stimulated mice, respectively). Thus, we now propose to further define the cellular, anatomical and molecular mechanisms that distinguish resident B-1 responses from those of immigrant B-1 cells, and to determine the extent to which other B cell compartments and receptor interactions contribute to the innate response. Together, these studies will provide grounds for developing a comprehensive and informative model of the complex innate immunity mechanisms involved in natural antibody responses that must be produced rapidly to minimize damage due to invading pathogens. Public Health Relevance: Studies proposed here are designed to provide a clear view of the B cells and mechanisms that participate in innate antibody responses to invading pathogens. Our findings to date demonstrate that we can work effectively with the tiny functional B cell subsets that mediate these responses. These studies will provide grounds for developing a comprehensive and informative model of the complex innate immunity mechanisms involved in natural antibody responses that must be produced rapidly to minimize damage due to invading pathogens.
描述(由申请人提供):目前对脂多糖(例如,此处使用的来自鼠伤寒沙门氏菌的LPS)等细菌刺激的先天免疫反应的概念主要基于对取自未刺激小鼠的脾细胞进行体外刺激的数据。然而,我们最近在体内小鼠模型中进行 LPS 刺激的发现表明,大部分体外数据不适合模拟先天反应,而先天反应必然发生在体内。同样,我们的研究结果提出了如何将体内模型(B 细胞转基因、TLR 缺陷、寄生虫感染等)的数据与正常(基因完整)动物的 LPS 反应联系起来的问题。具体来说,我们发现体内大部分 LPS 刺激的浆细胞反应是由 B-1a (CD5+ B-1) 细胞产生的,其中大多数仅在注射 LPS 后迁移到脾脏中。此外,我们发现体内对 LPS 的立即反应是由驻留在脾脏中的 B-1a 细胞产生的,并且令人惊讶地在 1-2 天内分化为浆细胞,而无需进行细胞分裂。浆细胞分化的初始波占体内总体反应的相对较小比例,其在第 3 天达到峰值,并且主要由在分化为浆细胞之前(或同时)分裂的移民 B-1a 细胞产生。然而,早期反应者的快速反应能力(可比作原始免疫记忆)可能是利用先天免疫系统“填补空白”直至适应性免疫系统接管的能力的关键。这里提出的研究旨在提供对 B 细胞和参与对入侵病原体(包括但不限于 LPS)的先天抗体反应的机制的清晰认识。我们迄今为止的研究结果表明,我们可以有效地利用介导这些反应的微小功能性 B 细胞亚群(分别来自未刺激或 LPS 刺激小鼠的脾细胞的 0.1-3%)。因此,我们现在建议进一步定义区分驻留 B-1 反应与移民 B-1 细胞反应的细胞、解剖和分子机制,并确定其他 B 细胞区室和受体相互作用对先天反应的贡献程度。总之,这些研究将为开发涉及天然抗体反应的复杂先天免疫机制提供全面且信息丰富的模型,必须快速产生天然抗体反应,以最大程度地减少入侵病原体造成的损害。公共健康相关性:此处提出的研究旨在提供对参与对入侵病原体的先天抗体反应的 B 细胞和机制的清晰认识。我们迄今为止的研究结果表明,我们可以有效地利用介导这些反应的微小功能性 B 细胞亚群。这些研究将为开发涉及天然抗体反应的复杂先天免疫机制提供全面且信息丰富的模型,必须快速产生天然抗体反应,以最大程度地减少入侵病原体造成的损害。
项目成果
期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Layered evolution in the immune system: a view from history.
- DOI:10.1111/nyas.12795
- 发表时间:2015-12
- 期刊:
- 影响因子:5.2
- 作者:Herzenberg LA
- 通讯作者:Herzenberg LA
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Leonore A. Herzenberg其他文献
Surface markers and functional relationships of cells involved in murine B-lymphocyte differentiation.
参与鼠 B 淋巴细胞分化的细胞的表面标记和功能关系。
- DOI:
- 发表时间:
1977 - 期刊:
- 影响因子:0
- 作者:
Leonore A. Herzenberg;Samuel J. Black;Michael R. Loken;Ko Okumura;W. V. D. Loo;Barbara A. Osborne;D. Hewgill;James W. Goding;G. A. Gutman;Noel L. Warner - 通讯作者:
Noel L. Warner
Le phospho-FACS : un outil puissant d’exploration des cascades de transduction intracellulaires
磷酸化-FACS:细胞内转导级联的有力探索
- DOI:
- 发表时间:
2007 - 期刊:
- 影响因子:0
- 作者:
Y. Gernez;Leonore A. Herzenberg;Rabindra Tirouvanziam - 通讯作者:
Rabindra Tirouvanziam
Demonstration of B-cell maturation in X-linked immunodeficient mice by simultaneous three-colour immunofluorescence
通过同步三色免疫荧光证实 X 连锁免疫缺陷小鼠的 B 细胞成熟
- DOI:
- 发表时间:
1983 - 期刊:
- 影响因子:64.8
- 作者:
R. R. Hardy;K. Hayakawa;David R. Parks;Leonore A. Herzenberg - 通讯作者:
Leonore A. Herzenberg
Leonore A. Herzenberg的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Leonore A. Herzenberg', 18)}}的其他基金
Aire-dependent thymic B-1a cells play a key role in neonatal tolerance induction
Aire 依赖性胸腺 B-1a 细胞在新生儿耐受诱导中发挥关键作用
- 批准号:
10660882 - 财政年份:2023
- 资助金额:
$ 38.76万 - 项目类别:
Automated comparison of flow data from HIV and vaccine infected subjects.
自动比较 HIV 和疫苗感染受试者的流量数据。
- 批准号:
8636991 - 财政年份:2012
- 资助金额:
$ 38.76万 - 项目类别:
Automated comparison of flow data from HIV and vaccine infected subjects.
自动比较 HIV 和疫苗感染受试者的流量数据。
- 批准号:
8262983 - 财政年份:2012
- 资助金额:
$ 38.76万 - 项目类别:
Automated comparison of flow data from HIV and vaccine infected subjects.
自动比较 HIV 和疫苗感染受试者的流量数据。
- 批准号:
9303874 - 财政年份:2012
- 资助金额:
$ 38.76万 - 项目类别:
Automated comparison of flow data from HIV and vaccine infected subjects.
自动比较 HIV 和疫苗感染受试者的流量数据。
- 批准号:
8456054 - 财政年份:2012
- 资助金额:
$ 38.76万 - 项目类别:
Compensation Automation for HIV Vaccine Development
HIV 疫苗开发的补偿自动化
- 批准号:
8115478 - 财政年份:2010
- 资助金额:
$ 38.76万 - 项目类别:
Compensation Automation for HIV Vaccine Development
HIV 疫苗开发的补偿自动化
- 批准号:
7690404 - 财政年份:2008
- 资助金额:
$ 38.76万 - 项目类别:
相似国自然基金
建立新型的基因编辑小鼠生物反应器广谱表达抗肠毒素B(SEB)单克隆抗体
- 批准号:31900676
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
TLR4调控系统性红斑狼疮中自身反应性B-1a细胞活化的作用及机理研究
- 批准号:81901635
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
TRAF6/mTOR双向调控巨噬细胞极化在放疗联合PD-1抗体诱导远隔效应中的作用及机制研究
- 批准号:81903135
- 批准年份:2019
- 资助金额:20.5 万元
- 项目类别:青年科学基金项目
超高效免疫磁MOFs纳米材料设计及其在动物源样品前处理中的应用研究
- 批准号:31873026
- 批准年份:2018
- 资助金额:61.0 万元
- 项目类别:面上项目
哺乳动物细胞抗体人工进化平台的研究
- 批准号:31870923
- 批准年份:2018
- 资助金额:55.0 万元
- 项目类别:面上项目
相似海外基金
Achieving Sustained Control of Inflammation to Prevent Post-Traumatic Osteoarthritis (PTOA)
实现炎症的持续控制以预防创伤后骨关节炎 (PTOA)
- 批准号:
10641225 - 财政年份:2023
- 资助金额:
$ 38.76万 - 项目类别:
An immunotherapeutic IgY formulation against norovirus diarrhea
一种针对诺如病毒腹泻的免疫治疗 IgY 制剂
- 批准号:
10693530 - 财政年份:2023
- 资助金额:
$ 38.76万 - 项目类别:
Maturation of human humoral immunity through repeat malaria challenges
通过重复疟疾挑战使人体体液免疫成熟
- 批准号:
10720245 - 财政年份:2023
- 资助金额:
$ 38.76万 - 项目类别:
Pathogenicity of the emerging pathogen Kingella kingae
新出现的病原体金氏菌的致病性
- 批准号:
10559927 - 财政年份:2022
- 资助金额:
$ 38.76万 - 项目类别:
Low cost, Broad Spectrum Cancer Vaccine Targeting Human Papillomavirus
针对人乳头瘤病毒的低成本、广谱癌症疫苗
- 批准号:
10650067 - 财政年份:2022
- 资助金额:
$ 38.76万 - 项目类别: